Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and